Jean Pierre Bizzari - Aug 23, 2023 Form 3 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
Director
Signature
/s/ John Hamill, as Attorney-in-Fact
Stock symbol
APRE
Transactions as of
Aug 23, 2023
Transactions value $
$0
Form type
3
Date filed
8/24/2023, 09:45 PM
Previous filing
May 9, 2023
Next filing
Jan 2, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24.1 Power of Attorney